IL13 and atopic eczema: Tang et al. [34] showed that GOS supplementation contributed to a reduction in the plasma levels of pro-inflammatory cytokines such as IL-4, IL-13, IFN-γ, and TNF-α in a mouse model of atopic dermatitis.